Boston Scientific Corporation

BOVESPA:B1SX34 Stock Report

Market Cap: R$768.5b

Boston Scientific Future Growth

Future criteria checks 4/6

Boston Scientific is forecast to grow earnings and revenue by 23.2% and 10.2% per annum respectively. EPS is expected to grow by 22.8% per annum. Return on equity is forecast to be 17.3% in 3 years.

Key information

23.2%

Earnings growth rate

22.8%

EPS growth rate

Medical Equipment earnings growth18.3%
Revenue growth rate10.2%
Future return on equity17.3%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:B1SX34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202620,5103,4513,8924,40528
12/31/202518,6072,8432,8983,77731
12/31/202416,5771,9772,7273,79730
9/30/202415,9111,7932,1792,936N/A
6/30/202415,2291,8281,8662,632N/A
3/31/202414,7071,7651,7262,477N/A
12/31/202314,2401,5701,8222,503N/A
9/30/202313,7571,1911,7362,353N/A
6/30/202313,4008611,5592,125N/A
3/31/202313,0458461,2561,774N/A
12/31/202212,6826421,0081,526N/A
9/30/202212,5675966291,197N/A
6/30/202212,3298286681,192N/A
3/31/202212,1627541,0071,528N/A
12/31/202111,8889851,3981,870N/A
9/30/202111,4701,1011,7012,065N/A
6/30/202111,1965261,9392,243N/A
3/31/202110,1222011,6041,869N/A
12/31/20209,913-1151,2191,508N/A
9/30/202010,1083,6851,2421,527N/A
6/30/202010,1573,9801,0081,386N/A
3/31/202010,7854,2879861,409N/A
12/31/201910,7354,7001,4271,836N/A
9/30/201910,3921,0907821,163N/A
6/30/201910,0771,3968261,162N/A
3/31/20199,9371,797148467N/A
12/31/20189,8231,671-6310N/A
9/30/20189,670670686975N/A
6/30/20189,500521N/A926N/A
3/31/20189,267112N/A1,626N/A
12/31/20179,048104N/A1,426N/A
9/30/20178,831843N/A1,418N/A
6/30/20178,714788N/A935N/A
3/31/20178,582435N/A1,059N/A
12/31/20168,386347N/A1,182N/A
9/30/20168,09581N/A835N/A
6/30/20167,878-345N/A1,274N/A
3/31/20167,595-36N/A913N/A
12/31/20157,477-239N/A691N/A
9/30/20157,314-396N/A711N/A
6/30/20157,272-155N/A649N/A
3/31/20157,302-253N/A874N/A
12/31/20147,308-119N/A1,269N/A
9/30/20147,258288N/A1,104N/A
6/30/20147,147240N/A1,009N/A
3/31/20147,083366N/A1,121N/A
12/31/20137,070-121N/A1,110N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: B1SX34's forecast earnings growth (23.2% per year) is above the savings rate (10.4%).

Earnings vs Market: B1SX34's earnings (23.2% per year) are forecast to grow faster than the BR market (12.7% per year).

High Growth Earnings: B1SX34's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: B1SX34's revenue (10.2% per year) is forecast to grow faster than the BR market (7.3% per year).

High Growth Revenue: B1SX34's revenue (10.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: B1SX34's Return on Equity is forecast to be low in 3 years time (17.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y